ARLINGTON, Virginia – The U.S. Drug Enforcement Administration has initiated a significant operational reshuffle of its personnel stationed in the Dominican Republic following allegations of professional misconduct currently under federal investigation. This strategic repositioning emerges from an internal agency review aimed at preserving operational integrity while maintaining bilateral counter-narcotics cooperation.
In an official communiqué, the DEA characterized the move as a precautionary administrative measure designed to strengthen supervisory protocols and accountability mechanisms. The agency explicitly clarified that this reorganization does not constitute a reduction of its operational footprint in the Caribbean nation, but rather represents a structural realignment under enhanced compliance standards.
Personnel previously deployed to the Santo Domingo field office are being temporarily reassigned during the ongoing investigation. The DEA emphasized that this transitional phase will not impair collaborative anti-drug initiatives with Dominican authorities, noting that Administrator Anne Milgram has personally coordinated with the U.S. Ambassador to ensure an orderly transition process.
The agency highlighted the Dominican Republic’s critical geopolitical significance as a Caribbean logistics hub and praised the longstanding partnership with the country’s National Directorate for Drug Control (DNCD). This collaboration has produced substantial results in recent years, including major cocaine seizures and the disruption of transnational criminal syndicates operating in the region.
The DEA concluded its statement by affirming that the investigated conduct represents isolated incidents rather than institutional practice, reiterating its commitment to professional standards, transparency, and the rule of law in all international operations.